Los Angeles Capital Management
NERV icon

Los Angeles Capital Management’s Minerva Neurosciences NERV Stock Holding History

Los Angeles Capital Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,243
Closed -$116K – 1552
2021
Q2 		$116K Sell
6,243
-17,149
-73% -$369K ﹤0.01% 1509
2021
Q1 		$546K Buy
+23,392
New +$584K ﹤0.01% 1179

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Los Angeles Capital Management's NERV Position: Q3 2021 in Review

Los Angeles Capital Management sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 6,243 shares — an estimated $116K sold.

Los Angeles Capital Management first reported a position in NERV in Q1 2021 and held it in 2 quarters. The position peaked at $546K in Q1 2021. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • Los Angeles Capital Management reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 6,243 Minerva Neurosciences shares in Q3 2021, an estimated $116K.
  • Los Angeles Capital Management first reported a position in Minerva Neurosciences in Q1 2021 and held it in 2 quarters.
  • Los Angeles Capital Management's Minerva Neurosciences position peaked at $546K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on Los Angeles Capital Management's 13F filing for Q3 2021, filed 5 Nov 2021.